Activating T cells to fight cancer

Activating T cells to fight cancer

Marengo Therapeutics’ breakthrough discovery in T cell receptor (TCR) activation blazes a new trail for safe treatment and long-term protection against cancer. Immuno-oncology (IO) has transformed cancer care to significantly

Ipsen, continuing oncology push, pays a startup $45M for two cancer drugs

Ipsen, continuing oncology push, pays a startup $45M for two cancer drugs

Aiming to bolster a yearslong effort to build up an oncology business, French drugmaker Ipsen announced Monday a deal with startup Marengo Therapeutics to co-develop two potential cancer medicines. Marengo is relatively

Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer

Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer

Ipsen has been an active dealmaker lately, and it just struck another one that takes the pharmaceutical company into a new area of drug research. The Paris-based company is collaborating